Weiss Multi-Strategy Advisers’s Kite Pharma, Inc. KITE Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-33,000	Closed	-$1.51M	–	552
2016 Q1	$1.51M	Buy	+33,000	New	+$1.6M	0.07%	299
2015 Q1	–	Sell	-98,697	Closed	-$5.69M	–	571
2014 Q4	$5.69M	Buy	98,697 +88,697	+887%	+$3.73M	0.2%	114
2014 Q3	$285K	Buy	+10,000	New	+$247K	0.01%	479

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Weiss Multi-Strategy Advisers's KITE Position: Q2 2016 in Review

Weiss Multi-Strategy Advisers sold out of Kite Pharma, Inc. (KITE) in Q2 2016, closing a stake of 33,000 shares — an estimated $1.51M sold.

Weiss Multi-Strategy Advisers first reported a position in KITE in Q3 2014 and held it in 3 quarters. The position peaked at $5.69M in Q4 2014. 173 funds tracked by Wall St. Rank hold KITE as of Q2 2016.

Weiss Multi-Strategy Advisers reported no remaining Kite Pharma, Inc. position as of Q2 2016 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 33,000 Kite Pharma, Inc. shares in Q2 2016, an estimated $1.51M.
Weiss Multi-Strategy Advisers first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 3 quarters.
Weiss Multi-Strategy Advisers's Kite Pharma, Inc. position peaked at $5.69M in Q4 2014.
173 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2016.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2016, filed 15 Aug 2016.